Second, while we have shown that overexpression of TAL1/LMO1 and GSI treatment can induce TSPAN32, we have not yet performed targeted chromatin immunoprecipitation experiments to confirm direct binding of these factors to TSPAN32 regulatory regions in T-ALL cells. This evidence concerns the gene LMO1 and acute lymphoblastic leukemia.